Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

A live webcast will be available to all interested parties through the Investors section of Angiotech's website: www.angiotech.com/investors

                       ANGIOTECH PHARMACEUTICALS INC.
                    CONSOLIDATED STATEMENTS OF OPERATIONS

                                      (Unaudited)                   (Audited)
                              Three months ended                  Year ended
                                     December 31,                December 31,
    -------------------------------------------------------------------------

                              2009          2008          2009          2008

    REVENUE
    Product sales,
     net               $    49,975   $    46,054   $   191,951      $190,816
    Royalty revenue         13,533        15,676        62,171        91,546
    License fees                53           352        25,556           910
    -------------------------------------------------------------------------
                            63,561        62,082       279,678       283,272
    -------------------------------------------------------------------------

    EXPENSES
    Cost of products
     sold                   29,010        23,622       104,616       101,052
    License and royalty
     fees                    2,494         2,774        10,431        14,258
    Research and
     development             6,175         7,723        23,701        53,192
    Selling, general
     and administration     22,402        21,381        81,504        98,483
    Depreciation and
     amortization            8,406         8,421        33,251        33,998
    In-process research
     and development 
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant ... Inc. in excess of $10 million. The jury determined ... and that it improperly hired one or more of ... motions for judgment notwithstanding the verdict, a new trial, ...
(Date:2/26/2015)... The healthcare landscape is rapidly and radically changing. ... will host its 20 th Anniversary Medical Technologies ... to 10, at the Hilton San Diego Resort and Spa ... This event is a platform for global medical devices, diagnostics, ... and how to succeed in an uncertain future. ...
(Date:2/26/2015)... Pittsburgh, PA (PRWEB) February 26, 2015 ... March 9 -12, at the Ernest N. Morial ... 919 exhibitors (count as of February 19, 2015) ... community in industrial, academic, and government labs. The ... such as, but not limited to, analytical chemistry; ...
(Date:2/26/2015)... Innovation is more urgent than ever. Radical ... the world and transforming global markets in industry ... health care, disruption is constantly underway. , As ... shake the foundations of established business models, large-scale ... survive the next wave of mega-change. , This ...
Breaking Biology Technology:Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3Embrace the Future of Medical Technologies with Frost & Sullivan 2Embrace the Future of Medical Technologies with Frost & Sullivan 3Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2
... and Renewables into an Energy Portfolio , ... important component to America' energy future. In particular, ... Energy Efficiency into what many states call renewable ... The whole idea being that combining Energy Efficiency ...
... Corporation has been awarded the maximum $250,000 grant ... special SBIR grant program for its enzyme research. The ... and technologies with high potential value. , ,Under the ... by Lucigen from outside investors. , ,The award will ...
... aid technology development and labor training , ... Wis. Gov. Jim Doyle announced Thursday that 10 ... awards. The awards were made at the Wisconsin ... , ,My Grow Wisconsin Initiative calls for promoting economic ...
Cached Biology Technology:Energy efficiency is no longer the Rodney Dangerfield of energy 2Energy efficiency is no longer the Rodney Dangerfield of energy 3Wisconsin Development Fund awards announced 2Wisconsin Development Fund awards announced 3Wisconsin Development Fund awards announced 4
(Date:2/18/2015)...  Cepheid (NASDAQ: CPHD ) today announced that ... invited investors to participate via webcast. , Cowen and ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern Time ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern ... webcasts for these events, please visit Cepheid,s website at ...
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... St. Giles, UK, and Shenzhen, China 12 June, ... (NYSE: GE), and BGI, the world,s largest genomics organization, ... stem cell science. The objective of the collaboration is ... cell-derived assays for use in drug discovery and toxicity ...
... plant and animal pathogens deploy effector proteins as part ... of their hosts. New research has revealed the structure ... protein in the host. , Gram-negative bacterial pathogens can ... into host cells, to manipulate host cell processes for ...
... Genetically modified crops that produce insect-killing proteins from the ... sprays since 1996. These proteins are lethal to some ... creatures including humans. Yet, just as insects become ... to the Bt proteins in transgenic crops. ...
Cached Biology News:BGI, GE Healthcare team up on pioneering stem cell science projects 2The activity of a bacterial effector protein seen in molecular detail 2Bigger refuges needed to delay pest resistance to biotech corn 2Bigger refuges needed to delay pest resistance to biotech corn 3Bigger refuges needed to delay pest resistance to biotech corn 4
Opticon continuous fluorescence detector; includes optical base, analysis software, computer and monitor (this is an accessory for the DNA Engine thermal cyclers which must be ordered seperately)...
... ChipReader systems are highly sensitive laser confocal ... These are advanced scanners that meet your ... background level, and optimizing the signal on ... end of the range for increased sensitivity. ...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not...
... 400 System is an automated multiplexing platform ... SNP detection, pathogen sequence detection and pharmacogenetics ... be applied to an open and flexible ... be reused until all tests sites have ...
Biology Products: